In the article “Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody” by Agustin Melo-Carrillo, Rodrigo Noseda, Rony Nir, Aaron J. Schain, Jennifer Stratton, Andrew M. Strassman, and Rami Burstein, which appeared on pages 7149–7163 of the July 26, 2017 issue, the third author's first name is incorrect. The corrected author list is as follows: Agustin Melo-Carrillo, Rodrigo Noseda, Rony-Reuven Nir, Aaron J. Schain, Jennifer Stratton, Andrew M. Strassman, and Rami Burstein. The author line has been corrected on the online PDF version.